Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/CANTARGIA-AB-31837413/nieuws/Cantargia-rapporteert-nieuwe-preklinische-gegevens-over-het-potentieel-van-nadunolimab-om-het-anti-t-44891216/?utm_source=whatsapp&utm_medium=social&utm_campaign=share